[EN] CONTROLLED-DELIVERY CROMAKALIM PRODRUGS<br/>[FR] PROMÉDICAMENTS DE CROMAKALIM À LIBÉRATION CONTRÔLÉE
申请人:QLARIS BIO INC
公开号:WO2021119503A1
公开(公告)日:2021-06-17
The present invention provides cromakalim prodrugs, compositions, and their use for the modulation of ATP-sensitive potassium (KATP) channels for therapeutic purposes.
本发明提供了克罗马卡利姆前药、组合物及其用于调节ATP敏感性钾(KATP)通道以用于治疗目的的方法。